Table of Contents
What changed
Revenue was essentially flat at NZ$231.7m (FY20: NZ$233.9m, down 0.9%), but the operating and statutory lines diverged sharply. EBITDA (before depreciation, impairment, conversion costs, finance costs and tax) rose 44.5% to NZ$72.8m, while PBT deteriorated from a NZ$271.4m loss to a NZ$765.1m loss and NPAT widened from a NZ$198.3m loss to a NZ$552.6m loss. Operating cash inflow improved 9.7% to NZ$34.7m on roughly flat capex of NZ$33.4m, producing company-defined free cash flow of NZ$3.2m. Gross borrowings were cut 27.3% to NZ$199.7m and net debt fell to NZ$183.6m from NZ$231.3m, taking net debt/EBITDA from about 4.6x to about 2.5x. No dividend was declared. Equity declined 12.1% to NZ$495.5m as the loss absorbed retained earnings.
What matters
- The loss is strategy-driven, not operational. The EBITDA line, which excludes impairment and conversion costs, rose 44.5% on a modestly lower revenue base, consistent with the company's stated refinery simplification and the imminent transition to a fuels import terminal. The NZ$493.6m worsening in PBT against a NZ$22.4m improvement in EBITDA points to large impairment and conversion-related charges associated with that transition, rather than a deterioration in the underlying refining/processing business.
- Leverage strengthened against the loss. Despite the NZ$552.6m NPAT loss, net debt fell by roughly NZ$47.7m and the net debt/EBITDA ratio more than halved. That reconciles because the charges driving the loss are largely non-cash; operating cash flow actually rose.
- Cash conversion weakened relative to headline EBITDA. OCF/EBITDA fell to about 47.6% from 62.7%, as EBITDA improved faster than operating cash flow. Cash on hand also fell from NZ$43.3m to NZ$16.1m, primarily reflecting debt repayment rather than operating drain.
Expectations
No quantified forward-work or earnings guidance was disclosed in the extracted release. The HY21/FY21 split is informative: revenue was roughly even half-on-half (HY21 49.7% of full year) and EBITDA was first-half weighted (HY21 57%), but the NZ$552.6m NPAT loss was overwhelmingly second-half weighted (HY21 accounted for only ~0.9%). That timing is consistent with the second-half crystallisation of conversion-related impairments as the fuels import terminal decision moved from "in review" to "imminent." The release does not support any read on steady-state earnings under the new import-terminal model; it confirms the transition is proceeding and that balance-sheet capacity has been rebuilt ahead of it.
Quality of result
The operating improvement looks real but narrowly defined. EBITDA growth is supported by a 9.7% lift in operating cash flow and a material reduction in gross borrowings, neither of which is achievable from accounting presentation alone. However:
- The headline EBITDA figure is struck before impairment and conversion costs, and the release provides limited reconciliation back to statutory earnings, so the "underlying" read depends on accepting management's definition.
- Cash conversion deteriorated: OCF/EBITDA dropped roughly 15 percentage points, and receivable days of about 32 (trade debtors of NZ$20.6m against revenue of NZ$231.7m) against a near-zero prior-year trade debtor balance indicates a significant working-capital normalisation whose sustainability is not explained in the excerpts.
- Free cash flow of NZ$3.2m is thin in absolute terms and does not tie cleanly to a simple OCF-minus-capex of about NZ$1.2m, implying additional company adjustments.
Durability therefore rests on the post-transition business model rather than on the FY21 P&L.
Unresolved
- The split between impairment charges and conversion costs within the NZ$493.6m PBT deterioration, and whether further conversion-cost provisions are to come in FY22.
- The steady-state revenue, margin, and capex profile of the fuels import terminal model, including the reference to "incremental revenue over 10 years" cited in the excerpts without a fully quantified base.
- The drivers of the jump in trade debtors from NZ$7k to NZ$20.6m and whether this reflects a change in counterparty or billing arrangements under the new operating model.
- The reconciliation between company-defined free cash flow (NZ$3.2m) and the statutory OCF/capex outputs, and the components of "adjusted EBITDA" referenced at the half year.
- Capital allocation intent once the transition is complete, given the absence of a dividend and the improved leverage ratio.
This briefing cannot assess the economics of the post-conversion import terminal business or the adequacy of the FY21 impairment charges without asset-level disclosures and forward operating assumptions.
Key metrics
| Metric | FY21 | FY20 | Change |
|---|---|---|---|
| Revenue | $231.7m | $233.9m | -0.9% ↓ |
| EBITDA | $72.8m | $50.4m | +44.5% ↑ |
| Net profit after tax | −$552.6m | −$198.3m | -178.7% ↓ |
| Net cash inflow from operating activities | $34.7m | $31.6m | +9.7% ↑ |
| Declared dividend per share | 0.0c | — | — |
| Profit before tax | −$765.1m | −$271.4m | -181.9% ↓ |
| Cash and cash equivalents | $16.1m | $43.3m | -62.9% ↓ |
| Total assets | $1157.6m | $1167.9m | -0.9% ↓ |
Reference: annolyse.ai/briefings/chi-fy21
Analytical metrics
| Metric | FY21 | FY20 | Context |
|---|---|---|---|
| OCF / EBITDA (cash conversion) | 47.6% | 62.7% | deteriorated |
| FCF pre-lease | $1.2m | −$2.3m | +$3.6m |
| FCF post-lease | $3.2m | $1.2m | +$2.0m |
| FCF / NPAT | -0.6% | -0.6% | complementary conversion metric |
| Capex % revenue | 14.4% | 14.5% | — |
| Capex | $33.4m | −$33.9m | +$67.4m |
| Free cash flow | $3.2m | — | — |
| Debtor days | 32.4 | — | — |
| Trade debtors | $20.6m | $0.0m | +$20.6m |
| Net debt | $183.6m | $231.3m | −$47.7m |
| Net debt / EBITDA | 2.50x | 4.60x | Strengthening |
| Gross borrowings | $199.7m | $274.6m | −$74.9m |
| Payout ratio vs NPAT | 0.0% | — | — |
| Payout ratio vs FCF pre-lease | 0.0% | — | covered |
| ROE (annualised) | -111.5% | -35.2% | Weakening |
| HY21 share of FY21 revenue | 49.7% | — | Other half was 50.3% |
| HY21 share of FY21 EBITDA | 57.0% | — | Other half was 43.0% |
| HY21 share of FY21 NPAT | 0.9% | — | Other half was 99.1% |
| Profit from continuing operations | −$552.6m | — | — |
Reference: annolyse.ai/briefings/chi-fy21
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.